LAMPRENE 50 mg, soft capsule 100 capsules
Active ingredients: Clofazimine
Commercialized according to BDPMDispensing in France: Prescription only
Soft capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMPRENE 50 mg, capsule molle
- Pharmaceutical form
- capsule molle
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène de 100 capsule(s)
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Mar 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62768220CIP75602815CIP133400956028153Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLOFAZIMINEcapsule | 50,00 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.